Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Work In Process: 2020-2025

Historic Work In Process for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Sep 2025 value amounting to $9.7 million.

  • Maravai Lifesciences Holdings' Work In Process fell 9.73% to $9.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.7 million, marking a year-over-year decrease of 9.73%. This contributed to the annual value of $10.1 million for FY2024, which is 20.74% down from last year.
  • As of Q3 2025, Maravai Lifesciences Holdings' Work In Process stood at $9.7 million, which was down 7.77% from $10.5 million recorded in Q2 2025.
  • Maravai Lifesciences Holdings' 5-year Work In Process high stood at $30.6 million for Q3 2022, and its period low was $9.7 million during Q3 2025.
  • In the last 3 years, Maravai Lifesciences Holdings' Work In Process had a median value of $11.0 million in 2024 and averaged $12.4 million.
  • Its Work In Process has fluctuated over the past 5 years, first surged by 30.73% in 2022, then plummeted by 60.06% in 2023.
  • Quarterly analysis of 5 years shows Maravai Lifesciences Holdings' Work In Process stood at $21.4 million in 2021, then increased by 2.66% to $21.9 million in 2022, then crashed by 42.23% to $12.7 million in 2023, then fell by 20.74% to $10.1 million in 2024, then dropped by 9.73% to $9.7 million in 2025.
  • Its last three reported values are $9.7 million in Q3 2025, $10.5 million for Q2 2025, and $9.9 million during Q1 2025.